NEXTBLUE Opens Applications for 20 Femtech Startups Eyeing US Entry
The program treats US entry as a staged process of market fit, strategy, and local validation rather than a single training session, with MATTER handling acceleration and validation for the 10 companies that advance.
Reporting from 1 source: ASCII.jp.
NEXTBLUE has opened applications for "TOKYO to Global: Femtech & Healthcare Startup US Launchpad," a Tokyo Metropolitan Government project. The program selects 20 femtech and healthcare startups based in or expanding into Tokyo. Over about two years it covers US market fit, market understanding, entry strategy, and English pitch practice. Ten companies then join a Chicago-based MATTER accelerator, and up to 5 conduct US market validation.
Applications run from October 15 to December 28, 2026, and participation is free, with no investment or equity acquisition required. An online information session is set for November 4 from 10:00 to 10:30 JST, covering program content, eligibility, selection process, schedule, and the MATTER portion, with a Q&A. Registering for the session is not a condition for applying.
From February to May 2027, the 20 selected companies go through US market fit assessment and a total of 10 sessions on the US healthcare market, covering insurance, business development, fundraising, and market entry experience.
Synthesized by Yomimono from the 1 cited source below, including Japanese-language reporting where cited, then editorially reviewed before publishing.